BeiGene
BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to treat cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.
Eric Van Cutsem, Josep Tabernero, Michel Decreux, Lizzy Smyth, Lesley Fallowfield
This summit on GI cancers provided clinicians with an overview of the current treatment landscape and new therapies for certain GI cancers.
BeiGene
Slide kit describing the effectiveness of PD-1 inhibition as compared to chemotherapy in previously treated advanced non-small cell lung cancer (NSCLC).